Clinical trial
Stroke Prevention With Abciximab in Carotid Endarterectomy
NCT00178451 · University of Rochester, Other · Withdrawn
Key facts
| NCT number | NCT00178451 |
|---|---|
| Title | Stroke Prevention With Abciximab in Carotid Endarterectomy |
| Official title | Stroke Prevention With Abciximab in Carotid Endarterectomy |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carotid Stenosis |
| Intervention type | Drug |
| Interventions | Abciximab |
| Enrollment | 0 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: